Pertuzumab + Trastuzumab
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Pertuzumab
pertuzumab - Trastuzumab
trastuzumab
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| pertuzumab + trastuzumabES | 1,200 mg / 600 mg | Roche Registration Gmbh |
| Phesgo Solution for Subcutaneous Injection 1200/600 mgSGTW | 600 mg / 1,200 mg | ROCHE SINGAPORE PTE. LTD. |
| Phesgo 600mg/600mg/10ml solution for injection vialsGB | 600 mg / 1,200 mg | Roche Products Ltd |
| Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vialsGB | 600 mg / 1,200 mg | Roche Products Ltd |
| PHESGO SOLUTION FOR SUBCUTANEOUS INJECTION 1200MG/600MG IN 15MLHK | — | ROCHE HONG KONG LIMITED |
| PERJETA-HERCEPTINCA | 30 mg / 440 mg | HOFFMANN-LA ROCHE LIMITED |
| 賀雙妥皮下注射劑 1200/600毫克TW | — | 羅氏大藥廠股份有限公司 |
| 賀雙妥皮下注射劑 600/600毫克TW | — | 羅氏大藥廠股份有限公司 |
Same combination in other markets
These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.
- ES · PHESGO · 4 products · record
- GB · Phesgo 600mg/600mg/10ml solution for injection vials · 2 products · record
- MX · PHESGO · 1 products · record
- CA · PHESGO; PERJETA-HERCEPTIN · 3 products · record
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.